Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 2/2009

01-02-2009 | Article

Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area

Authors: M. Campbell-Thompson, L. R. Dixon, C. Wasserfall, M. Monroe, J. M. McGuigan, D. Schatz, J. M. Crawford, M. A. Atkinson

Published in: Diabetologia | Issue 2/2009

Login to get access

Abstract

Aims/hypothesis

Recent histological analysis of pancreases obtained from patients with long-standing type 1 diabetes identified chronic islet inflammation and limited evidence suggestive of beta cell replication. Studies in rodent models also suggest that beta cell replication can be induced by certain inflammatory cytokines and by gastrin. We therefore tested the hypothesis that beta cell replication is observed in non-autoimmune human pancreatic disorders in which localised inflammation or elevated gastrin levels are present.

Methods

Resected operative pancreatic specimens were obtained from patients diagnosed with primary adenocarcinoma (with or without chronic severe pancreatitis) or gastrinoma. Additional pancreatic tissue was obtained from autopsy control patients. Immunohistochemistry was used to assess fractional insulin area, beta cell number and replication rate and differentiation factors relevant to beta cell development.

Results

Fractional insulin area was similar among groups. Patients with pancreatic adenocarcinoma and localised chronic severe pancreatitis displayed significant increases in the number of single beta cells, as well as increased beta cell replication rate and levels of neurogenic differentiation 1 in islets. Patients with gastrinoma demonstrated significant increases in the number of single beta cells, but the beta cell replication rate and islet differentiation factor levels were similar to those in the control group.

Conclusions/interpretation

These findings indicate that chronic severe pancreatic inflammation can be associated with significant effects on beta cell number or replication rate, depending on the distribution of the cells. This information may prove useful for attempts seeking to design therapies aimed at inducing beta cell replication as a means of reversing diabetes.
Appendix
Available only for authorised users
Literature
1.
Atkinson MA, Rhodes CJ (2005) Pancreatic regeneration in type 1 diabetes: dreams on a deserted islet. Diabetologia 48:2200–2202PubMedCrossRef
2.
Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration. Diabetologia 48:2221–2228PubMedCrossRef
3.
4.
5.
Lipsett M, Aikin R, Hanley S, Al-Maleek J, Laganiere S, Rosenburg L (2006) Islet neogenesis: a potential therapeutic tool in type 1 diabetes. Int J Biochem Cell Biol 38:715–720PubMedCrossRef
6.
Nir T, Melton DA, Dor Y (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117:2553–2561PubMedCrossRef
7.
Bonner-Weir S, Sharma A (2006) Are there pancreatic progenitor cells from which new islets form after birth. Nat Clinical Pract 2:240–241CrossRef
8.
Menge BA, Tannapfel A, Belyaev O et al (2008) Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes 57:142–149PubMedCrossRef
9.
Baeyens L, De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L (2005) In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48:49–57PubMedCrossRef
10.
Yang L, Li S, Hatch H et al (2002) In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A 99:8078–8083PubMedCrossRef
11.
Butler AE, Huang A, Rao PN et al (2007) Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans. Diabetes 56:1810–1816PubMedCrossRef
12.
Brand SJ, Tagerud S, Lambert P et al (2002) Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91:414–420PubMedCrossRef
13.
Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A (2005) Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54:2596–2601PubMedCrossRef
14.
Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R (2001) Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 12(Suppl 2):S95–S99PubMedCrossRef
15.
Meier JJ, Butler AE, Galasso R, Rizza RA, Butler PC (2006) Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia 49:2689–2696PubMedCrossRef
16.
Jones EM, Sarvetnick N (1997) Islet regeneration in IFNγ transgenic mice. Horm Metab Res 29:308–310PubMedCrossRef
17.
Luo X, Yang H, Kim IS et al (2005) Systemic transforming growth factor-β1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 79:1091–1096PubMedCrossRef
18.
Maedler K, Schumann DM, Sauter N et al (2006) Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:2713–2722PubMedCrossRef
19.
Smith U (2007) Introduction: symposium on diabetes, inflammation and cardiovascular disease. J Intern Med 262:142–144PubMedCrossRef
20.
Phillips JM, O’Reilly L, Bland C, Foulis AK, Cooke A (2007) Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration. Diabetes 56:634–640PubMedCrossRef
21.
Meier JJ, Butler AE, Saisho Y et al (2008) Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57:1584–1594PubMedCrossRef
22.
Sumi S, Gu Y, Hiura A, Inoue K (2004) Stem cells and regenerative medicine for diabetes mellitus. Pancreas 29:e85–e89PubMedCrossRef
23.
Zhang YQ, Sarvetnick N (2003) Development of cell markers for the identification and expansion of islet progenitor cells. Diabet Metab Res Rev 19:363–374CrossRef
24.
Zhang B, Lu Y, Campbell-Thompson M et al (2007) α1-Antitrypsin protects β-cells from apoptosis. Diabetes 56:1316–1323PubMedCrossRef
25.
Baggio LL, Drucker DJ (2006) Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57:265–281PubMedCrossRef
26.
27.
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef
28.
In’t Veld P, Lievens D, De Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404PubMedCrossRef
29.
Greider MH, McGuigan JE (1971) Cellular localization of gastrin in the human pancreas. Diabetes 20:387–396PubMed
30.
Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV (2007) The biology of cholecystokinin and gastrin peptides. Current Topics in Medicinal Chemistry 7:1154–1165PubMedCrossRef
31.
Dockray G, Dimaline R, Varro A (2005) Gastrin: old hormone, new functions. Pflugers Arch 449:344–355PubMedCrossRef
32.
Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844PubMedCrossRef
33.
Katsumichi I, Pour PM (2007) Diabetes mellitus in pancreatic cancer: is it a causal relationship. Am J Surg 194:S71–S75PubMedCrossRef
34.
Schmied BM, Ulrich AB, Friess H, Buchler MW, Pour PM (2001) The patterns of extrainsular endocrine cells in pancreatic cancer. Teratog Carcinog Mutagen 21:69–81PubMedCrossRef
35.
Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef
36.
Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B (2000) Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325–1333PubMedCrossRef
37.
Gianani R, Putnam A, Still T et al (2006) Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 91:1855–1861PubMedCrossRef
38.
Fellous TG, Guppy NJ, Brittan M, Alison MR (2007) Cellular pathways to beta-cell replacement. Diabetes Metab Res Rev 23:87–99PubMedCrossRef
39.
Mellitzer G, Martin M, Sidhoum-Jenny M et al (2004) Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice. Mol Endocrinol 18:2765–2776PubMedCrossRef
Metadata
Title
Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area
Authors
M. Campbell-Thompson
L. R. Dixon
C. Wasserfall
M. Monroe
J. M. McGuigan
D. Schatz
J. M. Crawford
M. A. Atkinson
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1200-z

Other articles of this Issue 2/2009

Diabetologia 2/2009 Go to the issue

Article

Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006

Article

The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice

Article

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Article

Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence

Short Communication

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

Letter

Congenital rubella and diabetes mellitus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits